Gene Therapies : How to make disruptive innovation affordable for patients ?

9:00 AM - 10:15 AM, Monday, June 3, 2019 ・ 1515 Market Avenue
Gene therapies have been disrupting the way to address fatal diseases, specifically for children. In fact, they have paved the way for various innovative curative therapies. However, these new therapies require a very different approach compared to what has typically existed in terms of drug development, drug production and commercialization, and the delivery to patients. This is especially true in light of the elevated costs that are currently passed on to patients. During this session, we will discuss what is behind such costs and how we can make gene therapies more affordable to patients. FREE event. Speakers : Pr Bruce Levine – Professor in Cancer Gene Therapy at U-penn, President elected at International Society of Cell & Gene therapy Pr Olivier Blin – Elected member of innovative medicines for EU Patricia Zilliox - CEO at Eyevensis Kristin Feerst - Integrated Solutions at Pall Biosciences Moderator : Michael Salgaller - Supervisory Invention Development at National Institutes of Health / National Cancer Institute. Mandatory Registration & Photo ID :
Barbara and Edward Netter Professor in Cancer Gene Therapy, is the Director of the Clinical Cell and
Penn Medicine
Integrated Solutions at Pall Biosciences